ArticleJournal of biophotonics2026
Quantitative Mapping of Fibrotic Tissue Mechanics via Brillouin Spectroscopy.
Article in Journal of biophotonics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oncogene-Mechanics Axis: KRAS G12C Confers Agility Enabling Malignant Mechano-responses to Peristalsis in Colorectal Cancer.bioRxiv : the preprint server for biology · 2026Article
- Quantitative Mapping of Fibrotic Tissue Mechanics via Brillouin Spectroscopy.Journal of biophotonics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Fibrosis is a pathological scarring process that disrupts tissue architecture, and is characterized by excessive extracellular matrix (ECM) deposition, leading to tissue stiffening and impaired organ function. Accurate quantification and spatial mapping of fibrotic tissue mechanics are critical for diagnosis, monitoring disease progression, and evaluating therapeutic responses. Here, we employ Brillouin microspectroscopy, a non-invasive, label-free optical technique, to quantify the mechanical properties of human fibrotic tissue in in situ. We show that Brillouin spectroscopy distinguishes fibrotic tissue from healthy tissue on the basis of localized differences in the complex longitudinal modulus and enables real-time monitoring of dynamic alterations in viscoelastic properties during fibrogenesis. To our knowledge, this is the first demonstration of Brillouin spectroscopy for in situ characterization of fibrosis and wound healing in a human model. These findings underscore Brillouin microspectroscopy's potential application as a promising diagnostic and monitoring tool for fibrotic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.